We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+16.25%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$26.9B
AUM Growth
+$5.25B
Cap. Flow
+$2.28B
Cap. Flow %
8.49%
Top 10 Hldgs %
25.71%
Holding
2,122
New
483
Increased
1,399
Reduced
210
Closed
29

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$148M
2
NVDA icon
NVIDIA
NVDA
+$57.1M
3
BABA icon
Alibaba
BABA
+$52.4M
4
TSLA icon
Tesla
TSLA
+$41.3M
5
STMP
Stamps.com, Inc.
STMP
+$37.6M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Consumer Discretionary 15.7%
3 Industrials 10.47%
4 Communication Services 9.84%
5 Healthcare 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RESN
2076
DELISTED
Resonant Inc.
RESN
$30K ﹤0.01%
+11,279
New +$26.6K
PVLA
2077
Palvella Therapeutics
PVLA
$1.98B
$29K ﹤0.01%
+147
New +$30.6K
FRBK
2078
DELISTED
Republic First Bancorp Inc
FRBK
$29K ﹤0.01%
+10,068
New +$26.6K
ADMA icon
2079
ADMA Biologics
ADMA
$1.92B
$28K ﹤0.01%
14,603
-6,689
-31% -$14.1K
SRGA
2080
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$28K ﹤0.01%
+427
New +$27.8K
SLNO
2081
DELISTED
Soleno Therapeutics
SLNO
$25K ﹤0.01%
+880
New +$25.4K
DHX icon
2082
DHI Group
DHX
$166M
$24K ﹤0.01%
+10,633
New +$21.8K
XCUR icon
2083
Exicure
XCUR
$11.2M
$23K ﹤0.01%
+88
New +$22K
MLSS icon
2084
Milestone Scientific
MLSS
$34.5M
$22K ﹤0.01%
+10,192
New +$17.9K
TLPH icon
2085
Talphera
TLPH
$70.1M
$22K ﹤0.01%
+887
New +$27.1K
ABEO icon
2086
Abeona Therapeutics
ABEO
$345M
$21K ﹤0.01%
+535
New +$18.2K
CRBP icon
2087
Corbus Pharmaceuticals
CRBP
$170M
$21K ﹤0.01%
567
-177
-24% -$6.62K
TYME
2088
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$19K ﹤0.01%
+15,387
New +$15.7K
MBII
2089
DELISTED
Marrone Bio Innovations, Inc.
MBII
$19K ﹤0.01%
+15,364
New +$18.3K
RMTI icon
2090
Rockwell Medical
RMTI
$26.2M
$16K ﹤0.01%
+140
New +$15.7K
SB icon
2091
Safe Bulkers
SB
$781M
$15K ﹤0.01%
+11,497
New +$12.4K
EXPR
2092
DELISTED
Express, Inc.
EXPR
$13K ﹤0.01%
+704
New +$13.3K
SVRA icon
2093
Savara
SVRA
$1.13B
$12K ﹤0.01%
+10,669
New +$12.9K
EYPT icon
2094
EyePoint Inc
EYPT
$1.02B
-2,018
Closed -$10K
CBIO
2095
Crescent Biopharma
CBIO
$602M
-122
Closed -$38K
HYG icon
2096
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
-5,301
Closed -$445K
LBTYA icon
2097
Liberty Global Class A
LBTYA
$3.31B
-133,924
Closed -$2.81M
LXRX icon
2098
Lexicon Pharmaceuticals
LXRX
$1.02B
-22,321
Closed -$32K
OPTN
2099
DELISTED
OptiNose
OPTN
-844
Closed -$49K
SLDB icon
2100
Solid Biosciences
SLDB
$771M
-697
Closed -$21K

Similar funds

ProShare Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, ProShare Advisors held 2,122 positions worth $26.9B, up 24% from $21.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

ProShare Advisors deployed $2.28B of net new capital in Q4 2020, opening 483 new positions and adding to 1,399 existing holdings. Its largest new stake was Keurig Dr Pepper: 1,170,659 shares worth $37.5M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $32.9M trimmed.

  • ProShare Advisors's largest Q4 2020 buy was Keurig Dr Pepper: 1,170,659 shares worth $37.5M.
  • ProShare Advisors added most to Amazon in Q4 2020, an estimated $148M increase.
  • ProShare Advisors's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $32.9M.
  • ProShare Advisors fully exited The Aaron's Company Inc Class A in Q4 2020, selling an estimated $26.2M.
  • ProShare Advisors's ten largest holdings make up 26% of its $26.9B portfolio in Q4 2020.
  • ProShare Advisors opened 483 new positions and closed 29 in Q4 2020.
  • ProShare Advisors's portfolio value rose 24% quarter-over-quarter to $26.9B.

Based on ProShare Advisors's 13F filing for Q4 2020, filed 9 Feb 2021.